Literature DB >> 30124792

The Functional Role of Large-scale Brain Network Coordination in Placebo-induced Anxiolysis.

Benjamin Meyer1,2, Kenneth S L Yuen1,2, Victor Saase1,2, Raffael Kalisch1,2.   

Abstract

Anxiety reduction through mere expectation of anxiolytic treatment effects (placebo anxiolysis) has enormous clinical importance. Recent behavioral and electrophysiological data suggest that placebo anxiolysis involves reduced vigilance and enhanced internalization of attention; however, the underlying neurobiological mechanisms are not yet clear. Given the fundamental function of intrinsic connectivity networks (ICNs) in basic cognitive processes, we investigated ICN activity patterns associated with externally and internally directed mental states under the influence of an anxiolytic placebo medication. Based on recent findings, we specifically analyzed the functional role of the rostral anterior cingulate cortex (rACC) in coordinating placebo-dependent cue-related (phasic) and cue-unrelated (sustained) network activity. Under placebo, we observed a down-regulation of the entire salience network (SN), particularly in response to threatening cues. The rACC exhibited enhanced cue-unrelated functional connectivity (FC) with the SN, which correlated with reductions in tonic arousal and anxiety. Hence, apart from the frequently reported modulation of aversive cue responses, the rACC appears to be crucially involved in exerting a tonically dampening control over salience-responsive structures. In line with a more internally directed mental state, we also found enhanced FC within the default mode network (DMN), again predicting reductions in anxiety under placebo.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anxiety; attention; fMRI; intrinsic connectivity networks; placebo effect

Year:  2019        PMID: 30124792     DOI: 10.1093/cercor/bhy188

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  5 in total

1.  Baseline functional connectivity may predict placebo responses to accelerated rTMS treatment in major depression.

Authors:  Guo-Rong Wu; Xiaowan Wang; Chris Baeken
Journal:  Hum Brain Mapp       Date:  2019-10-21       Impact factor: 5.038

2.  Placebos without deception reduce self-report and neural measures of emotional distress.

Authors:  Darwin A Guevarra; Jason S Moser; Tor D Wager; Ethan Kross
Journal:  Nat Commun       Date:  2020-07-29       Impact factor: 14.919

3.  Cortical Excitability Dynamics During Fear Processing.

Authors:  Venkata C Chirumamilla; Gabriel Gonzalez-Escamilla; Nabin Koirala; Tamara Bonertz; Sarah von Grotthus; Muthuraman Muthuraman; Sergiu Groppa
Journal:  Front Neurosci       Date:  2019-06-04       Impact factor: 4.677

4.  Changes in neural processing and evaluation of negative facial expressions after administration of an open-label placebo.

Authors:  Anne Schienle; Isabella Unger; Daniela Schwab
Journal:  Sci Rep       Date:  2022-04-21       Impact factor: 4.996

5.  Functional Neuroimaging Correlates of Placebo Response in Patients With Depressive or Anxiety Disorders: A Systematic Review.

Authors:  Nathan T M Huneke; Ibrahim H Aslan; Harry Fagan; Naomi Phillips; Rhea Tanna; Samuele Cortese; Matthew Garner; David S Baldwin
Journal:  Int J Neuropsychopharmacol       Date:  2022-06-21       Impact factor: 5.678

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.